Psoriasis

In this Healio exclusive video, Laura Korb Ferris, MD, discusses the importance of assessing racial and ethnic diversity in phase 3 clinical trials of risankizumab for the treatment of plaque psoriasis.

Long-term use of guselkumab in the treatment of psoriasis does not yield increased cancer rates compared with the general and psoriasis populations, according to a study.

NEW ORLEANS — Apremilast 30 mg significantly improved genital psoriasis severity and quality of life compared with placebo in the first trial to study an oral treatment for this indication, according to a presentation here.

Healio spoke with Linda Stein Gold, MD, director of dermatology clinical research at Henry Ford Health, about the most difficult-to-treat body areas for psoriasis, treatment options, unmet needs in these cases and more.

The American Academy of Dermatology Annual Meeting this year included clinical trial announcements and informative lectures in a wide variety of indications.

NEW ORLEANS — Pregnant women with eczema or psoriasis may need to exercise increased caution when evaluating treatment options, according to a presentation at the American Academy of Dermatology Annual Meeting.

Tremfya demonstrated greater treatment persistence than interleukin-17 inhibitors in patients with moderate to severe plaque psoriasis and achieved clinical efficacy in scalp psoriasis, according to data presented here.

The European Commission has approved Sotyktu in the European Union for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy, Bristol Myers Squibb announced in a press release.

NEW ORLEANS — Patients with psoriasis who had suboptimal results with prior interleukin-17 therapy experienced beneficial results with risankizumab, according to a presenter at the American Academy of Dermatology Annual Meeting.

NEW ORLEANS — Oral roflumilast may offer an inexpensive and effective treatment option for patients with psoriasis who are candidates for systemic therapy, according to a presentation at the American Academy of Dermatology Annual Meeting.